Beam Therapeutics Inc.(BEAM)NASDAQ
Stock Performance & Returns
Peer Comparison
Relative scale, growth, and profitability vs sector peers
| Ticker | Market Cap | P/E Ratio | Revenue Growth | Net Margin | EPS | ROE | Debt/Equity | Dividend Yield | 52W High | 52W Low |
|---|---|---|---|---|---|---|---|---|---|---|
BEAM | 3.04 B | -42.70x | -94.20% | -55.45% | $-0.69 | -8.18% | 0.23 | - | $38.26 | $16.02 |
FOLD | - | - | - | - | - | - | - | - | - | - |
VRTX | 141.42 B | 32.33x | 12.50% | 35.00% | $17.26 | 23.54% | 9.77 | - | $555.69 | $374.17 |
MRNA | 59.43 B | -18.66x | 2.10% | -1.41% | $-7.98 | -39.00% | 0.19 | - | $176.66 | $22.28 |
ALNY | 35.39 B | 45.45x | 66.90% | 16.13% | $5.82 | 96.56% | 2.21 | - | $495.55 | $197.81 |
CRSP | 5.46 B | -12.15x | 10.41% | - | $-4.65 | -26.10% | 0.45 | - | $78.48 | $44.12 |
Peer Valuation & Performance Analysis
Peer group analysis for Beam Therapeutics Inc. (BEAM) compared to its primary competitors (including FOLD, VRTX, MRNA) reveals distinct metrics. BEAM trades at a valuation discount relative to its competitors, with a P/E ratio of -42.7x versus the peer average of 8.6x (representing a 594% discount). This discount might represent an undervalued entry opportunity or reflect specific risk factors the market is discounting. In terms of growth, BEAM's revenue growth of -94.2% lags behind the peer average of 9.1%, indicating potential market share losses or slower industry adoption. Additionally, its net margin of -55.5% is below the peer average of 16.6%, suggesting higher operational costs or lower pricing power relative to peers.
Peer Performance Rankings
Ranking comparison across key performance metrics
P/E Ratio (Lower is Better)
Revenue Growth
Net Profit Margin
Financial Rankings Summary
• BEAM ranks #0 in P/E ratio, #5 in revenue growth, and #5 in profit margins
• Average ranking: #3 - 📊 Solid financials relative to peer group
• Rankings based on actual financial data from company reports
Historical Trading Data
Price and volume data with customizable timeframes
Showing 15 of 15 trading sessions from the last 15 days
| Date | Open | High | Low | Close | Volume | Daily Change |
|---|---|---|---|---|---|---|
| 2026-09-03 | $29.49 | $29.65 | $28.02 | $29.46 | 1,266,600 | -0.10% |
| 2026-09-02 | $29.27 | $30.18 | $28.23 | $29.29 | 1,292,200 | +0.07% |
| 2026-09-01 | $28.82 | $29.56 | $28.70 | $29.02 | 887,900 | +0.69% |
| 2026-08-31 | $28.82 | $29.82 | $28.33 | $29.43 | 1,308,000 | +2.12% |
| 2026-08-28 | $29.53 | $30.50 | $29.01 | $29.32 | 1,330,100 | -0.70% |
| 2026-08-27 | $30.14 | $30.82 | $29.72 | $30.48 | 1,268,800 | +1.13% |
| 2026-08-26 | $30.96 | $31.02 | $29.76 | $30.19 | 1,386,700 | -2.49% |
| 2026-08-25 | $28.94 | $31.48 | $28.78 | $31.03 | 2,187,300 | +7.22% |
| 2026-08-24 | $29.25 | $29.35 | $28.23 | $28.33 | 1,244,500 | -3.15% |
| 2026-08-21 | $28.74 | $30.50 | $28.61 | $29.76 | 2,457,300 | +3.55% |
| 2026-08-20 | $28.08 | $29.10 | $26.98 | $28.39 | 2,409,500 | +1.10% |
| 2026-08-19 | $28.41 | $29.16 | $27.64 | $29.07 | 3,102,600 | +2.32% |
| 2026-08-18 | $26.18 | $26.93 | $26.00 | $26.57 | 1,194,400 | +1.49% |
| 2026-08-17 | $26.52 | $27.24 | $26.40 | $27.10 | 1,470,200 | +2.19% |
| 2026-08-14 | $26.64 | $26.88 | $25.71 | $26.75 | 1,228,400 | +0.41% |
Explore More Analysis for BEAM
Additional research, tools, and technical breakdowns
Stock Analyzer Report
Deep-dive automated research and stock rating report.
DCF Fair Value Calculator
Discounted cash flow model and intrinsic value projection.
AI Price Predictions
Multi-scenario price predictions and consensus targets.
Insider Activity Tracker
Track buying/selling behavior of corporate insiders.
Earnings Calendar
Track upcoming and historical corporate earnings reports.
Market Insights & Research
Read the latest analysis articles and expert research.